This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at

UnitedHealth Group (UNH) stock is still down 40% YTD but has surged more than +20% this month following reports that Warren Buffett, and other billionaire hedge fund managers have taken a stake in the company.

UnitedHealth Group (UNH) stock continues to be under pressure, down more than 50% since mid-April. Wall Street remains concerned about the health insurance giant’s rising medical costs and the potential impact on Medicare Advantage margins and near-term earnings.

Following an investment by Warren Buffett's Berkshire Hathaway, many eyes are on the healthcare insurer these days.

UnitedHealth Group completed its $3.3 billion purchase of Baton Rouge-based Amedisys Thursday morning, more than two years after plans to join the nation's two largest home health and hospice care companies were first announced.

Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008.

UnitedHealth was a star stock late last week, when it was revealed that Warren Buffett's Berkshire Hathaway had taken a $1.6 billion stake in the company's equity. On Monday, lingering positive sentiment on UnitedHealth was boosted by that price target bump.

Warren Buffett's Berkshire Hathaway increased its holdings in UnitedHealth Group stock, and also added positions in D.R. Horton, Lamar Advertising, and Nucor.

Democratic Sens. Ron Wyden (Ore.) and Elizabeth Warren (Mass.) are launching an investigation into UnitedHealth Group (UHG) over its actions reportedly steering seniors away from hospital visits

Meanwhile, the healthcare giant pays an $8.84 annual dividend, yielding about 3.38%. UnitedHealth has raised its dividend for 15 consecutive years, including a 5.2% increase last quarter. You're collecting a sizable yield backed by roughly $30 billion in annual operating cash flow, giving you steady income while you wait for the recovery.

The seller was Amulet Capital Partners L.P., a private equity firm based in Greenwich, Conn. Amulet founded U.S. Digestive Health in 2019. The sale price to UnitedHealth was not disclosed.